Safe-Harbor In-Browser De-Identification|Zero EHR Friction

Never let an insurer dictate your patient’s treatment plan.

Akeso AI ingests messy chart notes and payer denial faxes to generate citation-grounded appeal dossiers, peer-to-peer battle cards, and real-time patient status updates in under two minutes.

Start 14-Day Practice Pilot
HIPAA Safe-Harbor De-Identification EngineGrounded on 2026 Payer Clinical Policy Bulletins (CPBs)Trusted by leading Dermatology & Rheumatology private clinics
Raw payer denial fax + EHR note

UHC_DENIAL_PT-8812.pdf • 8 pages  ·  DERM_ENCOUNTER.pdf • 14 pages

“Denied: Step therapy required. Patient must fail Adalimumab and Methotrexate before IL-23 approval.”

  • CARC 197 / RARC N425 — prior authorization criteria not met
  • Scanned fax quality: 91% OCR confidence
  • Chart note is unstructured, 14 pages, mixed dictation
Akeso synthesis

Ingesting the 14-page chart & synthesizing clinical evidence…

Overturn-ready Akeso dossier

APPEAL_PT-8812_L1.pdf • 6 pages + enclosures

  • UnitedHealthcare expedited Level 1 carrier coversheet pre-filled
  • Adalimumab discontinued — secondary loss of response (chart p. 6)
  • Methotrexate withdrawn for hepatotoxicity, ALT 148 / AST 121 (p. 9)
  • PASI 18.4 / BSA 12% severity documented (p. 3)
  • Cites AAD 2026 biologics guidance and payer CPB 2026D0044AA

The four pillars

Everything a specialty practice needs to win access

Built for independent Dermatology, Rheumatology, Gastroenterology and Oncology practices — not for hospital IT departments.

Zero-friction ingestion

Drag and drop multi-page PDFs, chart notes, or scanned faxes without a 9-month EHR integration project. No API keys, no IT ticket, no downtime.

Interactive evidence grounding

Every drug failure, lab value, and contraindication is cited with clickable chart source tags, so nothing reaches a payer that isn't in the record.

Autonomous status agent

Automate insurance hold calls and IVR navigation to retrieve claim status without burning coordinator hours on hold music.

End-to-end access suite

Specialty pharmacy routing, copay assistance matching, and a 60-day renewal countdown so approvals don't quietly lapse.

The problem

The administrative bottleneck costing your clinic time & revenue

Specialty denials are won on documentation, not persistence. Most clinics simply run out of hours.

Delayed patient care

Patients wait 3–6 weeks for life-changing biologics while disease progression worsens and flares escalate.

Staff burnout

Prior authorization coordinators spend 15+ hours per week manually parsing 8-page denial letters.

Unappealed revenue loss

Up to 40% of initial specialty rejections are never appealed due to lack of time and complex step-therapy mandates.

How it works

Three steps from denial letter to filed appeal

Average end-to-end time: under two minutes per case.

1

Upload documents

Drag & drop the insurer's denial letter or EOB alongside the patient's clinical encounter notes (PDF or scan).

2

AI clinical extraction

Akeso isolates CARC/RARC rejection codes, matches tried-and-failed medications, and checks the payer's Clinical Policy Bulletins.

3

One-click dossier export

Review the editable, citation-backed appeal letter and download a structured, ready-to-fax PDF packet.

The platform

One workspace for the whole access workflow

Beyond the appeal letter — every tool your team reaches for after a denial lands.

P2P battle cards

Printable 30-second rebuttals for the physician's peer-to-peer call.

Step-therapy bypass

Scores fail-first exemptions against payer policy and state statutes.

Payer dispatch hub

Secure e-fax or portal-ready export with a statutory deadline clock.

Renewal radar

60-day re-authorization countdown so approvals never quietly lapse.

Biosimilar switch analyzer

Preferred-product checks and grounded medical-exception overrides.

Financial clearance

Copay & assistance enrollment plus buy-and-bill underwater alerts.

Rate & allowed-amount matrix

J-code reimbursement benchmarks per payer before you buy and bill.

Practice analytics

Overturn rates, turnaround time and recovered revenue by payer.

The accuracy & trust engine underneath

What makes the output defensible when a payer — or a physician — pushes back.

  • Payer & PBM intelligence engineLive coverage criteria and formulary-shift detection, with an ambiguity resolver for vague denial language.

  • Evidence groundingEvery clinical claim links back to a cited chart page; unsupported claims surface as gaps instead of being invented.

  • Clinical accuracy labContinuous benchmarking against a golden dataset for hallucination and citation accuracy.

  • Attestation & immutable audit trailClinician sign-off freezes the letter and its citations, with role-based staff access and a tamper-proof ledger.

  • Interoperability & fidelity monitorPayer FHIR coverage-status checks plus OCR fidelity scoring on scanned denial faxes.

  • BAA governance & renewal controlVendor agreement tracking with expiration reminders, versioned revisions, side-by-side diffs, guarded rollbacks and an exportable activity ledger — PHI transmission stays sandboxed until every agreement is in force.

Practice ROI calculator

Estimate the revenue your practice is leaving with the payer

3

1 to 15 providers

15

5 to 60 denials per month

Modeled on 1.4 coordinator hours per manual appeal and an average overturned biologic claim value of $4,200. Directional estimate — not a guarantee of outcome.

Staff hours saved monthly

~64 hours / month

Annual practice revenue protected

$318,000 / year

Akeso AI plan recommendation

Practice Pro Tier ($499/mo)

Claim your 14-day free pilot

Specialty coverage

Built for the therapies payers fight hardest

Dermatology

Skyrizi
Tremfya
Dupixent

Clinical data points extracted

PASI and BSA severity scores, DLQI impact, documented topical corticosteroid and phototherapy failures, and dates of every prior systemic trial.

Maps documented topical and phototherapy failures against each payer's step-therapy ladder and rebuts "insufficient severity" denials with quantified scores.

Default citation set: AAD 2026 psoriasis & atopic dermatitis biologics guidelines

From the practices using it

Trusted by billing teams across specialty medicine

Dermatology

Biologic denials used to eat two full days of my week between the fax log and chart digging. Now the dossier comes back cited, and I only review it before it goes out.

11 appeals/week handled by one coordinator

Danielle Ortiz

Practice Manager

Coastline Dermatology — 4 providers, Tampa FL

Rheumatology

The peer-to-peer card is what changed the calls. Our physician walks in with the payer's own bulletin language and the trial citations, not a printed chart note.

Peer-to-peer prep down to 6 minutes

Marcus Whitfield

Prior Authorization Lead

Ridgeview Rheumatology — independent practice, Boise ID

Gastroenterology / infusion

The underwater check caught two infusion starts that would have lost money at our acquisition cost. That alone paid for the year.

$41K in at-risk margin flagged before scheduling

Priya Raghunathan

Revenue Cycle Director

Northbend GI & Infusion — 7 providers, Columbus OH

Before / after

Appeal turnaround

3 days4 minutes

From denial fax received to a cited, payer-formatted dossier queued for physician attestation.

Blended overturn rate — all appeal levels

38%71%

Overturns on specialty drug denials across Level 1 appeals through external review, once appeals cite the payer's own coverage criteria and the failed step-therapy record. Level 1 appeals alone run higher, at 84.2%.

Names and figures are illustrative composites drawn from early pilot use, shown to explain typical outcomes — not audited customer guarantees.

Practice ROI, measured per provider

84.2%

Level 1 appeal win rate specifically

Based on early pilot data — full methodology to be published. Blended overturn rate across all appeal levels is 71%.

< 2 min

Time to generate a complete appeal package

12+ hrs

Coordinator time saved per provider weekly

$0

Implementation or EHR overhaul fees

Security & compliance

Enterprise-grade HIPAA posture from day one

Built with compliance officers in the room, not bolted on afterwards.

Client-side safe-harbor redaction

Direct patient identifiers are stripped locally in the browser before anything is transmitted.

Zero data retention (ZDR)

Strict BAAs guarantee clinical text is never retained or used to train third-party models.

End-to-end encryption

AES-256 at rest and TLS 1.3 in transit across every request and stored dossier.

Immutable audit logs

Every extraction, edit and export is logged for clinical governance and compliance review.

Signed HHS-standard BAA before your pilot begins — with expiration reminders, versioned revisions, guarded rollbacks and an exportable compliance ledger built in.

Pricing

One overturned biologic denial pays for the year

Save 20%

Starter

Single-provider practice getting denials under control.

$249/mo

Billed monthly, cancel anytime

  • Single-provider practice
  • 30 active cases per month
  • Full appeal & peer-to-peer generator
  • Browser-side PHI de-identification
Most popular

Practice Pro

For 2–5 provider practices with a dedicated PA coordinator.

$499/mo

Billed monthly, cancel anytime

  • 2–5 providers, unlimited cases
  • Automated patient SMS dispatcher
  • Specialty pharmacy tracker
  • 60-day renewal radar

Enterprise / MSO

Multi-location clinic groups and management organizations.

$899/mo

Billed monthly, cancel anytime

  • Multi-location clinics
  • Autonomous payer phone agent
  • Gold-Card statutory auditing
  • Dedicated clinical policy account manager

FAQ

Questions from billing leads

Start overturning unfair denials today

Run your first appeal dossier in the next ten minutes — no integration, no procurement cycle.